Ferrosoferric Oxide
-
Subject Areas on Research
- Brain Iron Assessment after Ferumoxytol-enhanced MRI in Children and Young Adults with Arteriovenous Malformations: A Case-Control Study.
- Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients.
- Comparison of ferumoxytol-enhanced MRA with conventional angiography for assessment of severity of transplant renal artery stenosis.
- Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.
- Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT.
- Dual contrast enhancement of both T1- and T2-weighted sequences using ultrasmall superparamagnetic iron oxide.
- Early change in ferumoxytol-enhanced magnetic resonance imaging signal suggests unstable human cerebral aneurysm: a pilot study.
- Emerging applications for ferumoxytol as a contrast agent in MRI.
- Enhanced adsorption of arsenic onto maghemites nanoparticles: As(III) as a probe of the surface structure and heterogeneity.
- Ferrous iron content of intravenous iron formulations.
- Ferumoxytol MRA for transcatheter aortic valve replacement planning with renal insufficiency.
- Focal nodular hyperplasia: intraindividual comparison of dynamic gadobenate dimeglumine- and ferucarbotran-enhanced magnetic resonance imaging.
- Gated thoracic magnetic resonance angiography at 3T: noncontrast versus blood pool contrast.
- High-resolution 3D volumetric contrast-enhanced MR angiography with a blood pool agent (ferumoxytol) for diagnostic evaluation of pediatric brain arteriovenous malformations.
- Imaging aspirin effect on macrophages in the wall of human cerebral aneurysms using ferumoxytol-enhanced MRI: preliminary results.
- Inflammation, macrophages, and targeted imaging in intracranial aneurysms.
- Macrophage imaging within human cerebral aneurysms wall using ferumoxytol-enhanced MRI: a pilot study.
- Molecular Imaging in Neurovascular Diseases: The Use of Ferumoxytol to Assess Cerebral Aneurysms and Arteriovenous Malformations.
- Molecular imaging of cerebrovascular lesions.
- Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI.
- Preparation of ultrafine magnetic biochar and activated carbon for pharmaceutical adsorption and subsequent degradation by ball milling.
- Randomized trial of intravenous iron-induced hypophosphatemia.
- Re: Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent.
- Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent.
- Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases.
- Safety and technique of ferumoxytol administration for MRI.
- Splenic magnetic resonance imaging using particulate agents.
- Superparamagnetic iron oxide labeling and transplantation of adipose-derived stem cells in middle cerebral artery occlusion-injured mice.
- Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging.
- The emerging role of ferumoxytol-enhanced MRI in the management of cerebrovascular lesions.
- The physics and neurobiology of magnetoreception.
- The synchronization of superparamagnetic beads driven by a micro-magnetic ratchet.
- Vascular artifact mimicking thrombosis on MR imaging using ferumoxytol as a contrast agent in abdominal vascular assessment.